Neuropathological Changes in Nakalanga Syndrome-A Case Report.
Nakalanga syndrome
Uganda
epilepsy
nodding syndrome
pituitary gland
post-mortem
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
23 Jan 2021
23 Jan 2021
Historique:
received:
23
12
2020
revised:
19
01
2021
accepted:
21
01
2021
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
28
1
2021
Statut:
epublish
Résumé
Nakalanga syndrome is a clinical manifestation of onchocerciasis-associated epilepsy characterized by stunting, delayed or absent secondary sexual development and skeletal deformities, and is often accompanied by epileptic seizures. The pathophysiology of Nakalanga syndrome is unknown. Here, we describe the post-mortem findings of a 17-year-old female who died with Nakalanga syndrome in northern Uganda. Macroscopic and histopathological examination of all major organs (liver, lungs, kidney and heart), including the brain and the pituitary gland, was performed. The suspected cause of death was malaria, and all major organs and pituitary gland appeared normal, except the lungs, which were edematous consistent with the malaria. Neuropathological changes include signs of neuro-inflammation (gliosis and activated microglia), which co-localized with tau-reactive neurofibrillary tangles and threads. The pathology was most abundant in the frontal cortex, thalamic and hypothalamic regions, and mesencephalon. The choroid plexus showed psammoma bodies. These findings indicate accelerated aging, probably due to repeated seizures. The neuropathological findings were similar to other persons who died with onchocerciasis-associated epilepsy. Examination of the pituitary gland did not reveal new information concerning the underlying pathophysiological mechanism of Nakalanga syndrome. Therefore, more post-mortem studies should be performed.
Identifiants
pubmed: 33498763
pii: pathogens10020116
doi: 10.3390/pathogens10020116
pmc: PMC7912209
pii:
doi:
Types de publication
Case Reports
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/M025489/1
Pays : United Kingdom
Organisme : European Research Council
ID : 671055
Pays : International
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Epileptic Disord. 2019 Oct 1;21(5):425-435
pubmed: 31649005
PLoS Negl Trop Dis. 2019 Jul 18;13(7):e0007407
pubmed: 31318857
Brain Res. 2016 Jan 1;1630:225-40
pubmed: 26556772
Acta Neuropathol. 2018 Nov;136(5):691-697
pubmed: 30219940
Am J Trop Med Hyg. 1996 Jan;54(1):80-3
pubmed: 8651377
World Neurosurg. 2016 Sep;93:120-6
pubmed: 27283183
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300
pubmed: 31314757
PLoS Negl Trop Dis. 2017 Feb 9;11(2):e0005201
pubmed: 28182652
Trans R Soc Trop Med Hyg. 1961 Mar;55:188-91
pubmed: 13767192
Arch Dis Child. 1969 Jun;44(235):291-303
pubmed: 5785179
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):525-7
pubmed: 9463656
BMC Res Notes. 2014 Nov 28;7:858
pubmed: 25430904
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Treat Respir Med. 2006;5(6):419-28
pubmed: 17154671
Ital J Anat Embryol. 2004 Jan-Mar;109(1):19-33
pubmed: 15141473
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1049-1058
pubmed: 31553445